The FDA has approved a new buprenorphine treatment option for people with opioid use disorder following clinical trials that tested its safety and efficacy.
Did you get the chance to view our Multidisciplinary Roundtable on some hot topics in treating patients with HIV? Here are some highlights that you may have missed.
Using a systematic review, researchers evaluated the use of low-dose combination triple and quadruple antihypertensives to manage hypertension in patients.
This COVID-19 roundup includes coverage of the combination of amubarvimab and romlusevimab to manage COVID-19 infection, the association between COVID-19 and incident diabetes, and the effectiveness of...
After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.